Stock Market Crash?
Stock Market Crash?
Investment manager Fiske (FKE) announced a trading update following the conclusion of its financial year to 30 June 2025.
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, notes the fall in the Company’s share price on 13 August 2025 which it believes was connected to postings
Genedrive PLC (AIM: GDR), the developer of rapid genetic testing technology, expects total income for the year ended 30 June to rise to around £1 million, up from £0.5 million
London stocks close the week on a high note. The blue-chip FTSE 100 rose 0.6%, while the mid-cap FTSE 250 edged up 0.1%. Despite the renewed geopolitical tension, the FTSE
Genedrive wins EU approval for rapid genetic test aimed at stroke and heart attack care
Investors shrugged off pessimism at the close of play on Friday. The FTSE 100 climbed by 1.1%, while the UK-centric FTSE 250 advanced by 1.6%. Gold reached a record high
North West Anglia Foundation NHS Trusts’ Peterborough City Hospital implements the Genedrive® CYP2C19-ID Kit for routine clinical use
Sealand Capital Galaxy (SCGL), an IT, Social Media & Technology company focused on consolidating compelling technology opportunities in the global marketplace, is pleased to announce that the Company’s strategic investee &
In its Trading Update on 10 December 2024, Centrica (CNA) announced a £300 million extension of the Company’s share repurchase programme to be completed by the end of September 2025.
Superior performance to laboratory test and alternative available point of care platforms
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, ALL ,